Skip to main content Accessibility help
×
Home
  • Print publication year: 2012
  • Online publication date: February 2013

Chapter 13.1 - Fetal infections

from Section 2 - Fetal disease

Summary

This chapter reviews the immune system and describes the current knowledge of its development during fetal life. It summarizes the capacity of the fetal immune system to respond to infectious pathogens and focuses on congenital infections. In tissues, immune cells like macrophages and dendritic cells (DCs) express specific receptors, such as toll-like receptors (TLRs), allowing them to recognize molecules called pathogen-associated molecular-patterns (PAMPs) that are specifically expressed by pathogens. The immune system develops during fetal life in order to be ready to control infectious microorganisms to which the infant will be exposed after birth. Immune effector functions are required to control pathogens but may lead to inflammatory responses that are potentially harmful to the fetus and to the placenta. Recent studies of the immune responses to some pathogens infecting the fetus have indicated that fetal T lymphocytes can develop effector functions similar to those of older children or adults.
References
O’Shea, JJ, Paul, WE. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 2010; 327(5969):1098–102.
Billingham, RE, Brent, L, Medawar, PB. Actively acquired tolerance of foreign cells. Nature 1953;172(4379):603–6.
Adkins, B, Leclerc, C, Marshall-Clarke, S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004;4(7):553–64.
Sarzotti, M, Robbins, DS, Hoffman, PM. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 1996;271(5256):1726–8.
Ridge, JP, Fuchs, EJ, Matzinger, P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 1996;271(5256):1723–6.
Forsthuber, T, Yip, HC, Lehmann, PV. Induction of TH1 and TH2 immunity in neonatal mice. Science 1996;271(5256):1728–30.
Marchant, A, Goldman, M. T cell-mediated immune responses in human newborns: ready to learn? Clin Exp Immunol 2005;141(1):10–18.
Tavian, M, Peault, B. Embryonic development of the human hematopoietic system. Int J Dev Biol 2005;49(2–3):243–50.
Lewis, DB, Wilson, CB. Developmental immunology and role of host defenses in fetal and neonatal susceptibility to infection. In: Remington, JS Klein, JO, Wilson, CB, Nizet, V, Maldonado, YA, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia, Elsevier Saunders. 2011; 80–191.
Goriely, S, Goldman, M. From tolerance to autoimmunity: is there a risk in early life vaccination? J Comp Pathol 2007;137 Suppl 1:S57–61.
Salio, M, Dulphy, N, Renneson, J, et al. Efficient priming of antigen-specific cytotoxic T lymphocytes by human cord blood dendritic cells. Int Immunol 2003;15(10):1265–73.
White, GP, Watt, PM, Holt, BJ, Holt, PG. Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO- T cells. J Immunol 2002;168(6):2820–7.
Suryani, S, Fulcher, DA, Santner-Nanan, B, et al. Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. Blood 2010;115(3):519–29.
Michaelsson, J, Mold, JE, McCune, JM, Nixon, DF. Regulation of T cell responses in the developing human fetus. J Immunol 2006;176(10):5741–8.
Mold, JE, Michaelsson, J, Burt, TD, et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008;322(5907):1562–5.
Maldonado, YA, Nizet, V, Klein, JO, Remington, JS, Wilson, CB. Current concepts of infection of the fetus and newborn infant. In: Remington, JS, Klein, JO, Wilson, CB, Nizet, V, Maldonado, YA, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia, Elsevier Saunders. 2011; 2–23.
Marchant, A, Appay, V, Van Der Sande, M, et al. Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest 2003;111(11):1747–55.
Pedron, B, Guerin, V, Jacquemard, F, et al. Comparison of CD8+ T cell responses to cytomegalovirus between human fetuses and their transmitter mothers. J Infect Dis 2007;196(7):1033–43.
Gibson, L, Dooley, S, Trzmielina, S, et al. Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants. J Infect Dis 2007;195(12):1789–98.
Gibson, L, Piccinini, G, Lilleri, D, et al. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection. J Immunol 2004;172(4):2256–64.
Miles, DJ, van der Sande, M, Jeffries, D, et al. Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J Virol 2007;81(11):5766–76.
Vermijlen, D, Brouwer, M, Donner, C, et al. Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med 2010;207(4):807–21.
Pass, RF, Stagno, S, Britt, WJ, Alford, CA. Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. J Infect Dis 1983;148(6):953–61.
Starr, SE, Tolpin, MD, Friedman, HM, Paucker, K, Plotkin, SA. Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers. J Infect Dis 1979;140(4):500–5.
Tu, W, Chen, S, Sharp, M, et al. Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J Immunol 2004;172(5):3260–7.
Renneson, J, Dutta, B, Goriely, S, et al. IL-12 and type I IFN response of neonatal myeloid DC to human CMV infection. Eur J Immunol 2009;39(10):2789–99.
Shetty, AK, Maldonado, YA. Human immunodeficiency virus/acquired immunodeficiency syndrome in the infant. In: Remington, JS, Klein, JO, Wilson, CB, Nizet, V, Maldonado, YA, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia, Elsevier Saunders. 2011; 622–60.
Luzuriaga, K, Holmes, D, Hereema, A, et al. HIV-1-specific cytotoxic T lymphocyte responses in the first year of life. J Immunol 1995;154(1):433–43.
Thobakgale, CF, Ramduth, D, Reddy, S, et al. Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants. J Virol 2007;81(23):12775–84.
Lohman, BL, Slyker, JA, Richardson, BA, et al. Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants. J Virol 2005;79(13):8121–30.
Streeck, H, Nixon, DF. T cell immunity in acute HIV-1 infection. J Infect Dis 2010;202 Suppl 2:S302–8.
Voelkerding, KV, Sandhaus, LM, Belov, L, et al. Clonal B-cell proliferation in an infant with congenital HIV infection and immune thrombocytopenia. Am J Clin Pathol 1988;90(4):470–4.
Pugatch, D, Sullivan, JL, Pikora, CA, Luzuriaga, K. Delayed generation of antibodies mediating human immunodeficiency virus type 1-specific antibody-dependent cellular cytotoxicity in vertically infected infants. WITS Study Group. Women and Infants Transmission Study. J Infect Dis 1997;176(3):643–8.
Munoz, M, Liesenfeld, O, Heimesaat, MM. Immunology of Toxoplasma gondii. Immunol Rev 2011;240(1):269–85.
Fatoohi, AF, Cozon, GJ, Wallon, M, et al. Cellular immunity to Toxoplasma gondii in congenitally infected newborns and immunocompetent infected hosts. Eur J Clin Microbiol Infect Dis 2003;22(3):181–4.
Ciardelli, L, Meroni, V, Avanzini, MA, et al. Early and accurate diagnosis of congenital toxoplasmosis. Pediatr Infect Dis J 2008;27(2):125–9.
Chapey, E, Wallon, M, Debize, G, Rabilloud, M, Peyron, F. Diagnosis of congenital toxoplasmosis by using a whole-blood gamma interferon release assay. J Clin Microbiol 2010;48(1):41–5.
Guglietta, S, Beghetto, E, Spadoni, A, et al. Age-dependent impairment of functional helper T cell responses to immunodominant epitopes of Toxoplasma gondii antigens in congenitally infected individuals. Microbes Infect 2007;9(2):127–33.
McLeod, R, Beem, MO, Estes, RG. Lymphocyte anergy specific to Toxoplasma gondii antigens in a baby with congenital toxoplasmosis. J Clin Lab Immunol 1985;17(3):149–53.
McLeod, R, Mack, DG, Boyer, K, et al. Phenotypes and functions of lymphocytes in congenital toxoplasmosis. J Lab Clin Med 1990;116(5):623–35.
Hara, T, Ohashi, S, Yamashita, Y, et al. Human V delta 2+ gamma delta T-cell tolerance to foreign antigens of Toxoplasma gondii. Proc Natl Acad Sci U S A 1996;93(10):5136–40.
Maldonado, YA. Less common protozoan and helminth infections. In: Remington, JS, Klein, JO, Wilson, CB, Nizet, V, Maldonado, YA, eds. Infectious Diseases of the Fetus and Newborn Infant. Philadelphia, Elsevier Saunders. 2011; 1042–54.
Hermann, E, Truyens, C, Alonso-Vega, C, et al. Human fetuses are able to mount an adultlike CD8 T-cell response. Blood 2002;100(6):2153–8.
Hermann, E, Alonso-Vega, C, Berthe, A, et al. Human congenital infection with Trypanosoma cruzi induces phenotypic and functional modifications of cord blood NK cells. Pediatr Res 2006;60(1):38–43.
Rodriguez, P, Truyens, C, Alonso-Vega, C, et al. [Serum levels for IgM and IgA antibodies to anti-trypanosoma cruzi in samples of blood from newborns from mothers with positive serology for Chagas disease]. Rev Soc Bras Med Trop 2005;38 Suppl 2:62–4.